Insulin-like growth factor I (lGF-1) is an ana bolic pleiotrophic factor essential for postnatal rat brain development, especially during the first 21 days, the "critical growth period." Cerebral hypoxic-ischemic in sults occurring during the perinatal period can result in neuronal necrosis and permanent brain damage. To un derstand the regulation of the action of IGF-I in response to such a metabolic insult, we investigated the gene ex pression of IGF-I, type I IGF receptor, IGF binding pro tein (IGFBP) 2, and IGFBP5 during the first 72 h after hypoxia-ischemia in the immature rat. At I h of recovery, messenger RNA (mRNA) levels of all IGF system com ponents were decreased throughout the hemisphere ipsi lateral to the carotid artery ligation. This decrease is more pronounced at 24 h of recovery, especially in areas vul-
nerable to hypoxic-ischemic injury, such as the thalamus and hippocampus. At 72 h of recovery, although IGFBP2 and type I IGF receptor mRNA levels remain sup pressed, gene expression of both IGF-I and IGFBP5 was activated in reactive astrocytes. Therefore, during the critical growth period in rats, the transcriptional levels of all IGF system components are extremely sensitive to metabolic perturbations associated with cerebral hypox ia-ischemia. The immediate decrease in IGF-I gene ex pression may be partially responsible for the impending neuronal death and selective vulnerability of myelinogen esis during the perinatal period. Key Words: Insulin-like growth factor I-Hypoxia-ischemia-IGFBPs-Gene ex pression-Brain injury. (Davison and Dobbing, 1968) . This critical growth period is characterized by accelerated dendritic growth, synaptic formation, and myelination of the axons, all of which are critical for brain cytoarchi tecture. Any disturbance in the cellular metabolism may lead to structural and functional defects, re sulting in permanent brain damage. It is during this period that IGF-I messenger RNA (mRNA) is ex pressed in large projection neurons, reaching max imum levels about postnatal day 12-14 (Bondy, 1991) . In addition, the type I IGF receptor (Bondy et aI., 1992) , IGF binding protein 2 (IGFBP2), and IGFBP5 (Bondy and Lee, 1993a) are all expressed at the highest levels coordinately with IGF-I dur ing this growth period, suggesting an autocrinel paracrine mode of action for IGF-l.
Although the functional importance of this space and time-specific expression of IGF system genes is not well understood, cell culture studies revealed the nonspecific trophic actions of IGF-I on all cultured brain cells. For example, IGF-I acts as a mitogen to central cholinergic and dopaminergic neurons (Knusel et aI., 1990) , regulates the mitotic cycle in cultured rat sympathetic neuroblasts (DiCicco-Bloom and Black, 1988) , and potentiates PMA-induced differentiation of SH-SY5Y neuro blastoma cells (P1'thlman et aI., 1991) . In addition, both in vivo and in vitro evidence supports a neu roprotective role for IGF-1. For example, IGF-I protects neurons against hypoglycemia in vitro (Cheng and Mattson, 1992) and against hypoxic ischemic injury in vivo (Gluckman et aI., 1992; Guan et aI., 1993) . Taken together, the nondiscrim inative trophic and neuroprotective effects, the ubiquitous presence of type I IGF receptor on all brain cells (Bondy, 1991) , and the developmental regulation of IGF system gene expression strongly support an important functional role for IGF-I in brain development, especially during the critical growth period.
Perinatal hypoxia-ischemia remains the leading cause of severe brain damage in newborn infants (Mulligan et aI., 1980; Hill and Volpe, 1981; Bjerre et aI., 1983; Gray et aI., 1993; Pasternak, 1993) . The combination of an asphyxial insult and impaired blood flow can deprive the young brain of oxygen and other essential nutrients (Low et aI., 1989 ). If not corrected in time, cellular oxidative phosphor ylation will be severely depressed, which will lead to neuronal damage and death (Silverstein et aI., 1984; Volpe et aI., 1985; Yager et a!., 1992; Van nucci, 1993) . Although both the neuropathologic (Rice et aI., 1981; Towfighi et aI., 1991) and cerebral metabolic (Palmer et a!., 1990; Vannucci et a!., 1994) effects of hypoxia-ischemia have been de scribed in the immature rat, the effect of hypoxia ischemia on IGF-I gene expression has not been investigated during the critical growth period, when its normal level of expression may be critical for brain development. Previous studies, using postna tal day 21 (P21) rats, showed a hypoxia-ischemia induced increase in IGF-I expression in reactive as trocytes at 3 days after insult (Gluckman et a!., 1992) . Because of the anabolic activity of lGF-I and its importance during the critical growth period (i.e., before P21), we investigated the gene expres sion of IGF-I and other IGF system components in immature rat brains after hypoxia-ischemia. Neo natal rats at 7 days (P7) after birth were used be cause the maturity of their brains is roughly com parable to that of a 32-34 weeks' gestation human fetus or newborn infant (Davison and Dobbing, 1968; Rice et a!., 1981) . To understand the impact of metabolic insult on IGF-I gene expression dur ing the critical growth period, we investigated the cellular distribution of mRNAs for IGF-I, type I IGF receptor, IGFBP2, and IGFBP5 in the perina-J Cereb Blood Flow Metab, Vol. 16, No.2, 1996 tal period during the first 72 h after hypoxia ischemia.
MATERIALS AND METHODS

Perinatal hypoxia-ischemia model
Pregnant Wistar rats (Charles River) were housed in individual cages and fed standard laboratory chow ad li bitum. Offspring were delivered vaginally, and litter size was adjusted to 10 pups/litter on the day of delivery and remained with the dam until the day of experimentation. Hypoxia-ischemia was induced in 7-day-old rat pups as previously described (Rice et aI., 1981 ) , with minor mod ifications. Before exposure to hypoxia (8% O2/92% N2), pups were placed in the 37"C water bath for 20 min fol lowed by 2.5 h of hypoxic exposure. Preliminary studies demonstrated that this period of pre warming produced a more uniform degree of damage in littermates but re quired a reduction in the hypoxic exposure to ensure sur vival. Unilateral common carotid artery ligation com bined with 8% oxygen produces brain damage predomi nantly in the territory of the middle cerebral artery of the cerebral hemisphere ipsilateral to the carotid artery oc clusion (Rice et aI., 1981 ) . Damage does not usually occur in the contralateral cerebral hemisphere or in either hemi sphere when the animal is exposed to arterial ligation or hypoxia alone. All rat pu p s were then returned to their dams for 1, 3, 5, 24, or 72 h, at which times they were killed by dec a pitation, and the brains were removed and frozen in isopentane at -40°C, and stored at -70°C until analyzed.
In situ hybridization
In situ hybridization histochemistry was used to exam ine the transcription of exogenous IGF-I gene and the expression of type I IGF receptor, IGFBP2, and IGFBP5. Rat IGF-I, type I IGF receptor, IGFBP2, and IGFBP5 chromosomal DNA (cDNA) clones were used for the syn thesis of cRNA probes, and each has been described in detail previously (Zhou and Bondy, 1993) . The cRNA probes were synthesized in 10 J.LI reaction mixture con taining 100 J.LCi each 35 S-cytidine triphosphate (CTP) and 35 S-uridine triphosphate (UTP; Amersham), 10 mM NaCl, 6 mM MgCI2, 40 mM Tris (pH 7.5), 2 mM spermi dine, 10 mM dithiothreitol (DTT), 500 J.LM each unlabeled adenosine triphosphate (ATP) and guanosine triphos phate (GTP), 25 J.LM each unlabeled UTP and CTP, 1 J.Lg linearized template, 15 units of the appropriate polymer ase (BRL) and 15 units RNasin (Promega). The reaction was incubated at 42°C for 60 min, after which the DNA template was removed by digestion with DNase I. Aver age specific activity of probes generated by this protocol was 2-3 x 10 8 dpm/J.Lg.
Before hybridization, tissue sections were warmed to 25°C, fixed in 4% formaldehyde, and acetylated in 0.25% acetic anhydride/O.l M triethanolamine hydrochloride/ 0.9% NaCI. Tissues were dehydrated through an ethanol gradient, delipidate d in chloroform, rehydrated, and air dried. The 35 S-labeled cRNA probes were added to fresh hybridization buffer (1 0 7 cpms/ml), which is composed of 50% formamide, 0.3 M NaCl, 20 mM Tris HCl (pH 8), 5 mM EDT A, 500 J.Lg transfer RNA (tRNA)/ml, 10% dex tran sulfate, 10 mM DTT, and 0.02% each of bovine se rum albumin (BSA), ticoll, and polyvinylpyrolidone. Hy bridization buffer was added to sections, which were then covered with glass coverslips and placed in humidified chambers overnight (1 4 h) at 55°C. Slides were then washed several times in 4 x standard saline citrate (SSC) to remove coverslips and hybridization buffer, and then dehydrated and immersed in 0.3 M NaCl, 50% formam ide, 20 mM Tris HCl, and 1 mM EDT A at 60°C for 15 min. Next sections were treated with RNase A (20 j.Lg/ml, Boe hringer Mannheim, Indianapolis, IN, U.S.A.) for 30 min at 37°C, and then passed through graded salt solutions, followed by a 15-min wash in 0.1 x SSC at 50°C. Slides were dehydrated and air-dried and apposed to Hyperfilm beta Max (Amersham) for 2-5 days and then dipped in Kodak NTB2 nuclear emulsion, stored with desiccant at 4°C for 6-1 5 days, developed, and stained with cresyl violet or hematoxylin and eosin for microscopic evalua tion.
Immunocytochemistry
Immunocytochemistry was used to identify reactive as trocytes in the injured neonatal brains. A biotin-avidin horseradish peroxidase method was used, employing a monoclonal antibody against glial fibrillary acidic protein (GFAP; Boehringer Mannheim). The immunocytochem istry was performed on fresh frozen tissue sections (1 6 fLm thickness) adjacent to those used for in situ hy bridization studies (Lee, Clemens, et aI., 1992) . After fix ing in Zamboni fixative and blocking in 10% normal goat serum, tissue sections were incubated with a 1:5 dilution of GF AP antibody as described. Thereafter, tissue sec tions were treated with biotinylated horse anti-mouse serum (1 :200) for 2 h followed by a 45-min incubation FIG. 1. Time course and distribution of insulin-like growth factor (IGF) sys tem gene expression during the first 72 h after hypoxia-ischemia in perina tal rat brain. Neonatal rat brains were obtained at 1, 24, and 72 h (three brains in each group) after the hypox ia-ischemia. Fresh frozen tissue sec tions were hybridized to IGF-I (first row), IGFBP5 (second row), IGFBP2 (third row) or type I IGF receptor (R1, fourth row) chromosomal RNA (cRNA) probes, processed, and exposed to autoradiographic film in the same ex periment. The messenger RNA (mRNA) levels for all IGF system components were decreased in the ipsilateral hemi sphere as early as 1 h, with the most pronounced reduction in the ventral basal thalamus and hippocampus. The decrease was more pronounced at 24 h. At 72 h of recovery, the cellular levels and distribution of IGF-I and IGFBP5 mRNA were different from those of IGFBP2 and R1. Whereas IGFBP2 and R1 mRNA levels remained suppressed, IGF-I and IGFBP5 mRNA levels were increased in the thalamus, hippocampus, and cortical regions. Bar = 2 mm. with steptavidin-peroxidase conjugate. The antigen antibody complex was visualized by incubation with 3,3' diaminobenzidin (DAB).
RESULTS
During the first 72 h of recovery from hypoxia ischemia, there was a dramatic change in gene tran scription levels for IGF-I, type I IGF receptor, IGFBP2, and IGFBP5 in neonatal rat brains (n = 3) at each time point evaluated (Fig. 1) . Normally, these IGF gene components are expressed at the highest levels in the relay stations of the somato sensory and cerebellar systems (Bondy, 1991; Bondy et aI., 1992; Lee et aI., 1992; Bondy and Lee, 1993a) . As early as 1 h after hypoxia-ischemia, a panoramic decrease in the expression of all IGF system components was seen in the whole hemi sphere ipsilateral to the ligated carotid artery ( Fig.  1 , left column). The decrease was more pronounced at 3 and 5 h (data not shown) and most striking at 24 h of recovery (middle column). Within the ipsilat eral hemisphere, this early decrease was more pro nounced in the thalamus, hippocampus, and cortex. By n h of recovery, however, the cellular distribu tion of mRNAs 'differed among IGF-I, IGFBP2, IGFBP5, and the type I IGF receptor. Whereas IGFBP2 and type I IGF receptor mRNA levels re mained decreased, there was a parallel increase in IGF-I and IGFBP5 mRNA levels in the ipsilateral hemisphere. Compared to the levels of expression observed at 24 h of recovery, the in crease was more pronounced in the thalamus for IGF-I and in the hippocampus and amygdala for both IGF-I and IGFBP5 (Fig. 1, right column) . However, the cellular pattern of the enhanced IGF-I and IGFBP5 gene expression was different from that in the contralateral hemisphere. Whereas their mRNA levels remained subnormal in the ven tral basal thalamus, they were much higher in the rest of the thalamic region, as well as in the hippo campus and amygdala, without any nuclear pattern. By comparison, throughout the first 72 h of recov ery, the cellular pattern and levels of gene expres sion in the contralateral hemisphere remained nor mal for all IGF system components examined, ex cept for an increase in IGF-I and IGFBP5 mRNA levels in the parasagittal cortex.
To understand the potential action of IGF-I at the cellular level during the first 72 h after hypoxia ischemia, we examined IGF-I and IGFBP5 mRNA cellular distribution in the ventral posterior thala mus (VPL) nuclei. There, IGF-I ( Fig. 2A) and IGFBP5 ( Fig. 2E ) mRNA are normally colocalized in large projection neurons, as seen in the contra lateral VPL, whereas IGFBP2 mRNA is in astro-cytes (Lee, Javedan, et al., 1992) . By 1 h of recov ery, IGF-I and IGFBP5 mRNA levels decreased progressively in these large projection neurons ( Fig.  2B and F) . By 24 h, the neuronal expression of IGF-I and IGFBP5 was completely resolved, whereas there were apparent signs of neuronal death, as evidenced by chromolysis and pyknotic nuclei ( Fig. 2C and G) . At 72 h, there was an in crease in IGF-I and IGFBP5 mRNA levels in the ipsilateral VPL, but this appeared to be in nonneu ronal cells ( Fig. 2D and H) . Because most neurons are gone at this stage and a similar distribution of GFAP-positive cells was seen on adjacent sections, these small, nondescriptive cells were dispersed in the ipsilateral VPL and were most likely to be re active astrocytes (Figs. 3B, 4A ). The distribution of reactive astrocytes resembled that of the cell pop ulation expressing the IGF-I gene (Figs. 3A, 4B ) as well as that for IGFBP5 (Figs. 3C, 4C) and IGFBP2 (Figs. 3D, 4E and F), but less pronounced for the latter two.
A similar distribution of IGF-I and IGFBP5 mRNA and GF AP-positive reactive astrocytes was also found in the hippocampus (Fig. 5) and amygdala (Fig. 6 ). There IGF-I mRNA was ex pressed at a high level (Figs. 5A, 6A) in some of the reactive astrocytes present at 72 h after ischemia (Figs. 5D, 6D ). IGFBP5 mRNA was expressed at a lower level in most of the same population of reac- (0), IGFBP5 (C), and type I IGF receptor (RI; E) mRNA on adjacent tissue sections is shown by film autoradiograph. In the ipsilateral hemisphere, the distribution of IGF-I and IGFBP5, but not IGFBP2 or R1, mRNA is similar to that of GFAP-positive astrocytes (8). No hybridization signal was detected when a sense chromosomal RNA (cRNA) probe to R1 was used (F). Bar = 2 mm. tive astrocytes in these two areas (Figs. 5B, 6B) . In contrast, IGFBP2 mRNA was below the limit of detection in both areas (Figs. 5C, 6C ). Although our data cannot establish the precise cellular localiza tion of IGF-I and IGFBP5, our current observa tions, also supported by previous studies, agree with the coexpression of IGF-I and IGFBP5 in re active astrocytes. Future study using combined im munocytochemistry and in situ hybridization will be needed to determine the colocalization.
DISCUSSION
Current evidence, including ours, supports the functional role of IGF-I during brain development, especially in the critical growth period. To under stand the regulation of IGF-I gene expression dur ing this period in response to a major disturbance in cellular metabolism, this study examined the effect of perinatal hypoxia-ischemia on the expression of IGF system genes in rat brain. Almost immediately after the hypoxia-ischemia, there was a panoramic decrease of mRNA levels of all IGF system com ponents in the ipsilateral hemisphere, especially in those areas most vulnerable to hypoxic-ischemic irtiury. This early decrease in IGF system gene ex pression, absent in adult rats or at postnatal day 21 (Gluckman et aI., 1992) , appears to be unique to neonatal rats. This decrease was more pronounced at 24 h, when neuronal death is well advanced. By 72 h, IGF-I and IGFBP5 gene expression was acti vated in reactive astrocytes congregated at areas of injury, whereas mRNA levels of other IGF system genes remained suppressed. The astrocytic IGF-I expression was probably involved in astrogliosis as sociated with brain tissue repair, which has been observed after hypoxia-ischemia in older rats (Gluckman et aI., 1992) and in a focal ischemia model (Lee, Clemens, et aI., 1992) . The coactiva tion of IGFBP5 gene expression in the same popu lation of astroglia with IGF-I has not been reported in older rats (Gluckman et aI., 1992) . Future studies using immunocytochemistry will be needed to eval uate whether the peptide levels were also increased for IGF-I and IGFBP5 in astrocytes. Overall, we described for the first time a coordinated early de crease in neuronal IGF-I and IGFBP5 mRNA lev els, as well as their late activation in reactive astro cytes.
A potential functional role of IGF-I in brain de velopment is indicated by its specific spatial temporal expression during the critical growth pe riod. In rats, IGF-I mRNA levels start to increase soon after birth exclusively in large projection neu rons, reach their maximum about postnatal day 12-14, and decline by the end of third postnatal week when the brains mature (Bondy et aI., 1992) . In ad dition, the type I IGF receptor (Bondy et aI., 1992) , IGFBP2 and IGFBP5 (Lee, Javedan, et aI., 1992; Bondy and Lee, 1993a) are all expressed at the highest levels coordinately with IGF-I, suggesting an autocrine/paracrine mode of action for IGF-I during this growth period. Whereas IGFBP2 is ex pressed primarily in astroglia, IGFBP5 is coex pressed with IGF-I in the same group of projection neurons in the relay stations of the somatosensory ) . Adjacent sections were hybridized to IGF-I (8), IGFBP5 (C), or IGFBP2 (Q, E) chromosomal RNA (cRNA) probes. The distribution of reactive astrocytes is similar to the distri bution of IGF-I-expressing cells (8) and, to a lesser 'extent, IGFBP5-expressing cells (C). In the same area, very few cells expressed the IGFBP2 (arrowheads in E), and these cells have small nuclei and little cytoplasm, as evidenced at high magnifi cation (D). Bar = 70 fLm (A, B, and C) and 35 fLm (D and E). and cerebellar systems (Bondy and Lee, 1993a) . To date, the functional role of IGF-I during this critical growth period is not well understood, but it is likely to be involved in regulating the heightened cellu lar metabolism required by the developing brain (Bondy et aI., 1992) .
After hypoxia-ischemia, the immediate decrease in IGF system gene expression indicates that the IGF system components are subject to metabolic regulation and perturbation during the critical growth period, which is characterized by acceler ated dendritic growth, synaptic formation, and my elination of the axons. All of these events require supplies of essential nutrients, as well as heightened cellular metabolism. During and after hypoxia ischemia, cerebral oxidative metabolism is severely compromised as a direct result of decreased deliv ery of glucose and oxygen to the neonatal brain (Vannucci, 1993) . Among all indicators of cellular metabolism, there is a persistent loss of cellular A TP, which in turn will affect those metabolic pro-J Cereb Blood Flow Metab. Vol. 16, No.2, 1996 cesses that require energy for their completion. In terestingly, similar hypoxic-ischemic disturbances at P21 did not result in the early decrease in mRNA levels (Gluckman et aI., 1992 ) of any IGF system components as seen at P7. It is therefore likely that IGF system gene expression is subject to metabolic regulation during the critical growth period, to which the normal expression of IGF-I and its activ ity are essential. Consequently, the early decrease in IGF-I expression may be partially responsible for the impending cell death that occurs within 24 h of recovery, especially in areas of myelinogenesis (Rice et aI., 1981) .
IGF-I is a potent stimulator in oligodendrocyte proliferation, differentiation, and survival. Oligo dendrocytes will not develop in culture unless the medium contains 10% fetal bovine serum or physi ological concentrations of IGF-I (McMorris et aI., 1986) . Through type I IGF receptors present on oli godendrocytes (Masters et aI., 1991) , IGF-I stimu lates their mitosis, induces immature glial precur-FIG. 5. Cellular distribution of insulin-like growth factor I (IGF-I), IGFBPS, and IGFBP2 messenger RNA (mRNA) and glial fibrillary acidic protein (GFAP)-positive astrocytes in the hippocampus at 72 h of recovery. Micrographs showed granule cell layer in dentate gyrus on adjacent sections hybridized to IGF-I (A), IGFBPS (B), or IGFBP2 (C) chromosomal RNA (cRNA) probes. In the same area, GFAP-positive, reactive astrocytes showed typical cellular processes and swollen cytoplasm (0). The distribution of reactive astrocytes was similar to the distribution of IGF-I-expressing cells and, to a lesser extent, IGFBP5-expressing cells (C).
The IGFBP2 mRNA level was below the detection limit. Bar = 17.S f.Lm.
sors to differentiate into oligodendrocytes (McMor ris and Dubois-Dalcz, 1988) , and promotes myelin production (McMorris et al., 1986; Mozell and Mc Morris, 1991) . More convincingly, transgenic mice that overexpress the IGF-I gene have larger brains with increased cell size, number, and myelin con tent (Carson et al., 1993) . Conversely, brains of mice with a deletion of the IGF-I gene are hypomy elinated (Beck et al., 1995) . In addition to its role in oligodendrogenesis, IGF-I also acts as a survival factor to prevent cell death in the oligodendrocyte lineage (Barres et al., 1992) . Therefore, the imme diate decrease in IGF-I mRNA levels may contrib ute to the selective vulnerability of myelinogenesis to hypoxia-ischemia in neonatal rat brain.
The late activation of IGF-I in reactive astrocytes has been reported in other models of neuronal in jury. In transected sciatic nerves, immunoreactive IGF-I is increased in reactive Schwann cells, reach ing a peak level in 2 weeks (Hansson et al., 1986) . Interestingly, infusing IGF-I into the sciatic nerve stimulates its regeneration, whether the injury was induced by mechanical crush (Kanje et al., 1989) , sectioning (Li et al., 1994) , or by freezing (Silver stein et al., 1984) . In the central nervous system, IGF-I gene expression is induced in reactive astro cytes during astrogliosis induced by mechanical le sion (Garcia-Estrada et al., 1992) , by ischemic in jury (Lee, Clemens, et al., 1992) , or by hypoxia ischemia at P21 (Gluckman et al., 1992) . Normally, IGF-I is expressed exclusively in neurons through out life. Only in the delayed phase of neuronal in jury i s the IGF-I gene activated in reactive astro cytes. The astrocytic IGF-I expression is most likely involved in the heightened metabolism re quired during astrogliosis. In fact, high levels of IGF-I mRNA were found in areas demonstrating high levels of 14 C-2-deoxyglucose uptake in a focal ischemia model (Bondy and Lee, 1993b) , support ing an anabolic role during astrogliosis.
In neonatal brain, another unique response of IGF system genes to hypoxia-ischemia is the coor dinated expression of IGF-I and IGFBP5, which was not observed at postnatal day 21 (Beilharz et al., 1993) . Normally, IGF-I and IGFBP5 mRNA are coexpressed in large projection neurons in relay sta-FIG. 6. Cellular alSUlDuuon OT InSUlin-lIK.e growm TaClOr I \IUr-I), lurot"" :), ana lurot"" O<:: messenger 1'11'll A \m1'1I'll A) ana glial fibrillary acidic protein (GFAP)-positive astrocytes in the amygdala at 72 h of recovery. Cellular distribution of IGF-I (A), IGFBP5 (B), and IGFBP2 (C) mRNA was compared with that of (0) GFAP-positive, reactive astrocytes in amygdala on adjacent sections. The distribution of reactive astrocytes most resembled that of IGF-I-expressing cells (A), some of which also expressed IGFBP5. The IGFBP2 mRNA level was below the detection limit. Bar = 17.5 fLm.
tions of somatosensory and cerebellar systems (Bondy and Lee, 1993a) . Soon after cerebral hyp oxia-ischemia in the immature rat, the neuronal ex pression of both IOF-I and IOFBP5 was decreased. However, by 72 h, there was a coactivation of both genes in reactive astrocytes. IOFBP5 is one of the six soluble IOFBPs that have been identified in the circulation and extracellular fluid (Clemmons, 1993) . These high-affinity proteins can modulate the biological activities of IOFs in a target tissue by transporting IOFs in and out of the vascular com partment, targeting IOFs to specific cell types, and modulating the interaction between IOFs and their receptors. To date, the mechanism of action of IOFBPs is not entirely understood but may largely depend on the affinity between a specific IOFBP and IOFs relative to IOFR-1. For example, IOFBP5 has the highest affinity for IOFs of all the IOFBPs, which is 50-fold greater than that of the IOFR-I at pH 7.4 (Cohick and Clemmons, 1993) . This high affinity is decreased when the IOFBP5-10F com plex binds to the extracellular matrix protein (Jones J Cereb Blood Flow Metab, Vol. 16, No.2, 1996 , where IOFs can be released to stimu late cellular growth. It is conceivable that IOF-I and IOFBP5 are made by reactive astrocytes and re leased in bound form, which will protect IOF-I from protease degradation. This IOF-I-IOFBP5 complex will diffuse away to other sites, such as the extra cellular matrix, for the anabolic action of IOF-1.
In summary, we found significant differences be tween the responses of the cerebral IOF system gene expression in immature (P7) rats and that re ported for older P21 rats. First, unlike those of older animals, the transcription levels of all IOF system gene components at P7 were decreased soon after metabolic disturbance in the ipsilateral hemisphere, especially in areas vulnerable to hypoxia-ischemia. This early decrease suggested that, during the crit ical growth period, IOF system gene expression in rat brain is subject to metabolic regulation. Second, there was a coordinated early decrease in neuro nal IOF-I and IOFBP5 mRNA levels, as well as a late activation of both genes in reactive astrocytes. The specific temporal and cellular expression of IGFBP5 and IGF-I suggest a unique regulatory mechanism of the action of IGF-I in areas of injury by IGFBP5 in the developing brain.
